login
Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Hepatitis C Cure Possible With New Drugs
Hepatitis C virus (HCV) infects liver cells and can cause cirrhosis and liver cancer. It affects about 3 percent of the world's population - and new treatments are urgently needed.
This month, Vertex Pharmaceuticals, based in Cambridge, Massachusetts, and drug behemoth Merck, headquartered in Whitehouse Station, New Jersey, both released promising results from late-stage clinical trials of their leading drugs against HCV.
The two treatments belong to the first wave of what pharmaceutical analysts think will be a profusion of HCV-targeting drugs that could ring up billions of dollars in annual sales.
"There certainly is blockbuster potential for new and efficacious drugs in hepatitis C," Nature quoted Hedwig Kresse, a drug-market analyst at Datamonitor in London, as saying.
Both Vertex's drug telaprevir and Merck's boceprevir block HCV's protease enzyme so that it cannot carry out one of its key tasks. All of HCV's proteins are initially produced as one long polyprotein, which needs to be cleaved into its component proteins by the protease. Blocking the protease prevents the virus from producing functional proteins.
The companies will submit their medicines to the US Food and Drug Administration by the end of this year, with an eye towards approval in mid-2011.
If approved, telaprevir and boceprevir will take the early lead in an HCV drug field that could grow to be worth 15 billion dollars by 2017, according to Irena Melnikova, a life-sciences analyst at TVM Capital in Boston, Massachusetts. The field is poised to become even more crowded in the coming years.
"There are still going to be a number of patients who fail [to be cured by] telaprevir or boceprevir," said Chang.
"There's plenty of market to still go after." Chang added.
Source-ANI
|
|
More News on: Drug Toxicity, Hepatitis A, Hepatitis B, Vasculitis , Silent Killer Diseases, Liver, Aplastic Anemia, Hepatitis C
 Comment & Contribute
|
|
08/16/2010
At http://www.Pozspaces.com.com we understand the loneliness. You send and receive flirts, send email, Ask the conseler[live], Read the most active blogs and dating tip just for you and much more. We have a chat room and instant messenger. Join today and find your sole mate. You have nothing to lose but the loneliness.
Reply |
Forward
08/16/2010
|
Medwonders Health Network
- Health News Index
- News Quick Links
 | News Central | | Health Watch | |
| Latest Health News | | Health In Focus | |
| News Category (500+) | | Breaking Health News | |
| Popular News | | Celebrating Life | |
| Health News and Press Release | | Medindia - Exclusive | |
| News Photo Gallery | | India Special | |
| News Video Gallery | | Lifestyle and Wellness | |
| News From Other Resources | |||
 |
Hepatitis C
Complete Medindia Resources
|
| News Categories: |
| » | Research: Bright Colored Chips can Cut Consumption by Half |
| » | Olympic Athlete's Body Via the 80-10-10 Raw Vegan Diet |
| » | Importance of Canned Foods To Help Tackle IOM Weight Of The Nation Recommendations, Highlights Study |
| » | US Rules Pomegranate Juice Claims Deceptive |
| » | Reducing Entrée Size Could Increase Fruit and Vegetable Intake in Children |
| More Diet News | |
|
Research Related News |
||||||||
| » | Personality Traits Linked To Longevity in Centenarians | » | Lack of Vitamin D in Diet Raises Stroke Risk in Japanese-Americans | |||||
| » | Why Bovine TB Continues to Spread Demystified in New Research | » | Seaweed Pill May Help Treat Arthritis | |||||
| » | P. Aeruginosa Infection Leads to Worse Outcomes and Increased Hospitalizations in COPD Patients | » | Hormone Boosts Production of Molecules Which Fight Skin Infection | |||||
| » | Protein Discovery Could Lead To New Vaccine for Meningitis | » | Qui Vive: Intense Nuclear Radiation Threat, Scientists | |||||
| Read More >> | ||||||||
